pioglitazone / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT04976283: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Recruiting
4
123
RoW
Pioglitazone, Zolid, Empagliflozin, Diampa, Pioglitazone + Empagliflozin, Zolid + Diampa
Getz Pharma
Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD
05/23
11/23
EPIDOTE, NCT03499704: A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

Active, not recruiting
4
133
RoW
Pioglitazone + Alogliptin, SYR-322-4833, Alogliptin, Metformin, Dapagliflozin
Celltrion Pharm, Inc.
Diabetes Mellitus, Type 2
01/24
06/24
NCT06399835: Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Recruiting
4
120
RoW
Enavogliflozin, Envlo Tab., Pioglitazone, Actos Tab.
Seoul National University Bundang Hospital, Daewoong Pharmaceutical Co. LTD.
Type 2 Diabetes
06/26
12/26

Download Options